Histone deacetylase inhibitors in cancer therapy
Open Access
- 1 July 2003
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 4 (1), 13-18
- https://doi.org/10.1016/s1535-6108(03)00165-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8–mediated apoptosis and down-regulation of c-FLIP proteinBlood, 2003
- Molecular sequelae of histone deacetylase inhibition in human malignant B cellsBlood, 2003
- Histone deacetylase inhibitors: from target to clinical trialsExpert Opinion on Investigational Drugs, 2002
- Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) α and β messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cellsCancer Letters, 2002
- Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatmentBlood, 2002
- Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescenceThe EMBO Journal, 2002
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription FactorScience, 2002
- ApoptosisCell, 2002
- Translating the Histone CodeScience, 2001